Marie-Claude Laplace

653 total citations
16 papers, 562 citations indexed

About

Marie-Claude Laplace is a scholar working on Hematology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Marie-Claude Laplace has authored 16 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Marie-Claude Laplace's work include Blood Coagulation and Thrombosis Mechanisms (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Receptor Mechanisms and Signaling (4 papers). Marie-Claude Laplace is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Receptor Mechanisms and Signaling (4 papers). Marie-Claude Laplace collaborates with scholars based in France and Israel. Marie-Claude Laplace's co-authors include Pierre Savi, Jean‐Marc Herbert, J.P. Maffrand, Paul Schaeffer, Évelyne Dupuy, G Tobelem, Reut Shavit, Jean‐Marc Zini, J. M. Herbert and Frédérique Dol and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and FEBS Letters.

In The Last Decade

Marie-Claude Laplace

15 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marie-Claude Laplace France 12 182 167 155 75 69 16 562
Xi Lei Canada 10 124 0.7× 175 1.0× 134 0.9× 27 0.4× 63 0.9× 19 539
Analia Garcia United States 10 224 1.2× 264 1.6× 171 1.1× 19 0.3× 51 0.7× 13 532
Rebecca A. Houliston United Kingdom 9 83 0.5× 95 0.6× 299 1.9× 22 0.3× 44 0.6× 9 534
Darryl A. Higuchi United States 11 42 0.2× 337 2.0× 173 1.1× 21 0.3× 37 0.5× 12 770
Holger Summer Germany 10 173 1.0× 41 0.2× 324 2.1× 54 0.7× 47 0.7× 14 660
Bicheng Nan United States 12 34 0.2× 69 0.4× 319 2.1× 42 0.6× 61 0.9× 13 686
Alicia Zukas United States 9 116 0.6× 29 0.2× 170 1.1× 43 0.6× 107 1.6× 21 687
David S. Calnek United States 11 73 0.4× 41 0.2× 343 2.2× 12 0.2× 72 1.0× 12 607
G.Y. Shi United States 16 44 0.2× 74 0.4× 194 1.3× 49 0.7× 348 5.0× 28 766
Esther Lutgens Netherlands 8 94 0.5× 68 0.4× 221 1.4× 13 0.2× 84 1.2× 13 617

Countries citing papers authored by Marie-Claude Laplace

Since Specialization
Citations

This map shows the geographic impact of Marie-Claude Laplace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie-Claude Laplace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie-Claude Laplace more than expected).

Fields of papers citing papers by Marie-Claude Laplace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie-Claude Laplace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie-Claude Laplace. The network helps show where Marie-Claude Laplace may publish in the future.

Co-authorship network of co-authors of Marie-Claude Laplace

This figure shows the co-authorship network connecting the top 25 collaborators of Marie-Claude Laplace. A scholar is included among the top collaborators of Marie-Claude Laplace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie-Claude Laplace. Marie-Claude Laplace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Alam, Antoine, Isabelle Blanc, Olivier Duclos, et al.. (2012). SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic Activities. Molecular Cancer Therapeutics. 11(8). 1637–1649. 71 indexed citations
3.
Schaeffer, Paul, et al.. (2001). Detection of bradykinin B1 receptors in rat aortic smooth muscle cells. Biochemical Pharmacology. 61(3). 291–298. 17 indexed citations
4.
Schaeffer, Paul, et al.. (2000). Characterisation of the effects of SR146131, a novel non-peptide CCK1 receptor agonist, on IMR-32 human neuroblastoma cells. European Journal of Pharmacology. 397(2-3). 303–310. 4 indexed citations
5.
Schaeffer, Paul, et al.. (1997). Neurotensin induces the release of prostacyclin from human umbilical vein endothelial cells in vitro and increases plasma prostacyclin levels in the rat. European Journal of Pharmacology. 323(2-3). 215–221. 13 indexed citations
6.
Savi, Pierre, E Heilmann, Paquita Nurden, et al.. (1996). Clopidogrel: An Antithrombotic Drug Acting on the ADP-dependent Activation Pathway of Human Platelets. Clinical and Applied Thrombosis/Hemostasis. 2(1). 35–42. 50 indexed citations
7.
Schaeffer, Paul, et al.. (1995). Human Umbilical Vein Endothelial Cells Express High Affinity Neurotensin Receptors Coupled to Intracellular Calcium Release. Journal of Biological Chemistry. 270(7). 3409–3413. 31 indexed citations
8.
Herbert, Jean‐Marc, Marie-Claude Laplace, Anne-Marie Marés, & F. Dol. (1995). Platelet-activating factor (PAF) is not an essential component of the cascade leading to smooth muscle cell proliferation following vascular injury. PubMed. 12(1). 49–57. 7 indexed citations
9.
Herbert, Jean‐Marc, et al.. (1994). Malformin-a1 inhibits the binding of interleukin-1β (il1β) and suppresses the expression of tissue factor in human endothelial cells and monocytes. Biochemical Pharmacology. 48(6). 1211–1217. 14 indexed citations
10.
Savi, Pierre, Marie-Claude Laplace, J.P. Maffrand, & Jean‐Marc Herbert. (1994). Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.. Journal of Pharmacology and Experimental Therapeutics. 269(2). 772–777. 95 indexed citations
11.
Savi, Pierre, Marie-Claude Laplace, & J. M. Herbert. (1994). Evidence for the existence of two different ADP-binding sites on rat platelets. Thrombosis Research. 76(2). 157–169. 35 indexed citations
12.
Herbert, Jean‐Marc, Évelyne Dupuy, Marie-Claude Laplace, et al.. (1994). Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway. Biochemical Journal. 303(1). 227–231. 85 indexed citations
13.
14.
Herbert, Jean Marc, et al.. (1992). Effect of SR 27417 on oedema formation induced in rabbit skin by platelet-activating factor or antigen. European Journal of Pharmacology. 216(2). 175–181. 7 indexed citations
15.
Herbert, Jean‐Marc, et al.. (1992). IL‐4 inhibits LPS‐, IL‐1β‐ and TNFα‐induced expression of tissue factor in endothelial cells and monocytes. FEBS Letters. 310(1). 31–33. 73 indexed citations
16.
Herbert, Jean‐Marc, A. Bernat, G Valette, et al.. (1991). Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 259(1). 44–51. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xi Lei Breakdown of academic impact, for papers by Analia Garcia Breakdown of academic impact, for papers by Rebecca A. Houliston Breakdown of academic impact, for papers by Darryl A. Higuchi Breakdown of academic impact, for papers by Holger Summer Breakdown of academic impact, for papers by Bicheng Nan Breakdown of academic impact, for papers by Alicia Zukas Breakdown of academic impact, for papers by David S. Calnek Breakdown of academic impact, for papers by G.Y. Shi Breakdown of academic impact, for papers by Esther Lutgens
Rankless by CCL
2026